Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,955 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07219030RecruitingPhase 1
Study of emraclidine in healthy older adults
This study tests how the drug emraclidine moves through the body in healthy older adults. It helps researchers understand how the drug is processed and whether it is safe.
Cypress, CaliforniaAges 65–85 - NCT07219368RecruitingPhase 1
Testing a new drug (MT-201) safety in healthy adults
This trial tests a new medicine called MT-201 to see if it is safe and how the body handles it. It is for healthy volunteers aged 19 to 55 who are willing to follow study rules.
San Diego, CaliforniaAges 19–55 - NCT07219602RecruitingPhase 3
Study of obicetrapib and ezetimibe for diabetes and metabolic syndrome
This trial tests a combination medication (obicetrapib plus ezetimibe) taken daily to lower cholesterol and triglycerides in people with type 2 diabetes or metabolic syndrome who are already on standard cholesterol treatment. It may help reduce heart risks.
Sun City West, ArizonaAges 18 years+ - NCT07220122RecruitingEarly Phase 1
Do ketones affect breathing in healthy volunteers?
This study tests if a special drink with ketones can change how you breathe. It's for healthy people who don't have sleep or breathing problems.
Baltimore, MarylandAges 18–50 - NCT07220408RecruitingPhase 2
TL-925 eye drops for seasonal eye allergies
This trial tests an investigational eye drop called TL-925 for people with seasonal allergic conjunctivitis (eye allergies triggered by pollen, grass, etc.). It aims to see if TL-925 can relieve symptoms like redness and itching.
Smyrna, TennesseeAges 18 years+ - NCT07221214RecruitingPhase 2
Testing a diabetes drug for drinking and heart health in HIV
This trial tests if a once-weekly diabetes medication (semaglutide) can help people with HIV reduce heavy drinking and improve heart health. It's for people who drink alcohol and have a higher body weight.
Nashville, TennesseeAges 18–89 - NCT07221240RecruitingPhase 1
Amisodin safety study for healthy adults with ALS
This trial tests a new drug called Amisodin in healthy adults who also have ALS. It checks if the drug is safe and how the body processes it.
Baltimore, MarylandAges 18–55 - NCT07221344RecruitingPhase 1/Phase 2
Study of an experimental drug for early Alzheimer's disease
This study tests an investigational drug, ARO-MAPT-SC, which targets a protein involved in Alzheimer's disease. It is for people with early Alzheimer's to see if the drug is safe and can slow the disease.
East York, OntarioAges 18–80 - NCT07221370RecruitingPhase 2/Phase 3
Vancomycin to prevent C. diff infection in ICU patients
This trial tests whether giving vancomycin through a tube into the stomach can prevent a serious gut infection called C. diff in people who are very sick in the ICU and taking antibiotics. If you qualify, you might receive this medicine to lower your risk.
Moreno Valley, CaliforniaAges 18 years+ - NCT07222072RecruitingPhase 4
Methadone to reduce opioid use after spine surgery
This study tests whether giving methadone during and after major spine surgery can help reduce the need for other opioid pain medicines later. It is for adults having multilevel fusion in the lower or mid-back.
Cleveland, OhioAges 18–72 - NCT07222709RecruitingPhase 1
Healthy volunteer study of oral ABBV-1042
This trial tests the safety of a new oral drug, ABBV-1042, in healthy adults. It helps researchers understand how the drug moves through the body and what side effects may occur.
Grayslake, IllinoisAges 18–55 - NCT07224399RecruitingPhase 1
Testing a new injection for weight loss in obesity
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
Baltimore, MarylandAges 18–55 - NCT07225517RecruitingPhase 1
Safety study of BIIB145 in healthy adults
This study tests a new drug called BIIB145 in healthy volunteers to see if it's safe and how the body handles it. It helps researchers learn about the drug before testing it in people with specific conditions.
Austin, TexasAges 18–55 - NCT07227246RecruitingPhase 3
Testing rFVIIa for bleeding stroke within 2 hours
This trial tests whether a drug called Recombinant Factor VIIa (rFVIIa) can safely help stop bleeding in the brain during a hemorrhagic stroke. The goal is to give the drug as quickly as possible, within 2 hours of stroke onset, to see if it improves outcomes.
Birmingham, AlabamaAges 18–80 - NCT07227948RecruitingPhase 2
Testing semaglutide for cocaine use disorder
This study tests whether semaglutide, a medication used for weight management, can help reduce cocaine use in people with cocaine use disorder. You may qualify if you have a body mass index (BMI) of 25 or higher and recently used cocaine.
Houston, TexasAges 18 years+ - NCT07229261Recruiting
MitoQ for blood vessel health in preeclampsia
This study tests whether a supplement called MitoQ can improve blood vessel function in pregnant people with preeclampsia. It may help you if you have preeclampsia and are not planning to deliver right away.
Milwaukee, WisconsinAges 18–50 - NCT07229521Recruiting
Nattokinase for heart, gut, sleep, and brain health in metabolic syndrome with sleep issues
This study tests whether a supplement called nattokinase can improve heart health, sleep, thinking, and gut bacteria in people with metabolic syndrome and mild-to-moderate sleep apnea. If you have a larger waist, blood pressure or blood sugar issues, or imbalanced cholesterol, and have been diagnosed with mild or moderate sleep apnea, you may be eligible.
TaipeiAges 18 years+ - NCT07229911RecruitingPhase 1
Study of TAK-781 in healthy people and PSC patients
This study tests an investigational drug called TAK-781 in healthy volunteers and in people with primary sclerosing cholangitis (PSC) who do not have cirrhosis. The study aims to see how the drug is processed by the body and whether it is safe.
Salt Lake City, UtahAges 18–68 - NCT07229937RecruitingPhase 2
Testing an experimental drug for high cholesterol
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
Harbin, HeilongjiangAges 18 years+ - NCT07230652RecruitingPhase 1
Safety study of LY03020 for healthy volunteers and people with schizophrenia
This study tests the safety of a new medication called LY03020. It is for healthy volunteers and for people with stable schizophrenia. The study aims to see how well the body handles the drug and what side effects might occur.
BeijingAges 18–60 - NCT07231679RecruitingPhase 1/Phase 2
Testing IGT-303 for kidney disease from diabetes
This study tests a new drug called IGT-303 for people with chronic kidney disease caused by type 2 diabetes. It aims to see if the drug is safe and can help protect kidney function.
Herston, BrisbaneAges 18–75 - NCT07231783Recruiting
Urolithin A supplement for muscle strength in adults 40–65
This trial tests whether a daily supplement called Urolithin A (Mitopure®) can improve muscle strength in healthy middle-aged adults who are not very active. Researchers will measure changes in strength and fitness over several weeks.
CorkAges 40–65 - NCT07232121RecruitingPhase 1
Safety study of DF5112 in healthy adults
This study tests a new drug called DF5112 in healthy adults to find the safest dose. It helps doctors learn how the drug works in the body before testing it in people with a condition.
Sydney, New South WalesAges 18–55 - NCT07232758RecruitingPhase 1
Testing HRS-2183 Safety in Healthy Adults
This trial tests a new investigational drug called HRS-2183 in healthy volunteers to see how safe it is and how the body processes it after a single dose and after multiple doses. It's a first step in studying this potential medicine.
Jinan, ShandongAges 18–45
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,955 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.